Valence8 US »

C4 Therapeutics shares owned by Valence8 US

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Valence8 US from 13F filings

Historical chart of Valence8 US investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Valence8 US consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Valence8 US

Quarter filed Position value Share count Share price at filing
2024-09-30 $60k 11k 5.70

More positions owned by Valence8 US

Ishares Tr Msci Usa Qlt Fct (QUAL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Msci Intl Qualty (IQLT)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Index Fds Value Etf (VTV)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Ishares Tr Msci Uk Etf New (EWU)
Ishares Msci Jpn Etf New (EWJ)
Astrazeneca Sponsored Adr Call Option (AZN)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Amgen Put Option (AMGN)
Soleno Therapeutics (SLNO)
Insmed Com Par $.01 Call Option (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Bristol Myers Squibb (BMY)

View all positions for Valence8 US

Top funds holding C4 Therapeutics

Lynx1 Capital Management
Daniel D. Thurber
BlackRock
RA Capital Management
BlackRock
OrbiMed Advisors
Soleus Capital Management
Vanguard Group
Commodore Capital
State Street Corporation
Bank of America Corporation
Balyasny Asset Management
Silverarc Capital Management
Two Sigma Advisers
Geode Capital Management

View all funds holding C4 Therapeutics